Detalhe da pesquisa
1.
C3d-Targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complement.
Mol Ther
; 32(4): 1061-1079, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38382529
2.
Development and Optimization of Bifunctional Fusion Proteins to Locally Modulate Complement Activation in Diseased Tissue.
Front Immunol
; 13: 869725, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35784298
3.
The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor models.
Mol Cancer Ther
; 11(8): 1799-808, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22714264
4.
A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells.
J Pharmacol Exp Ther
; 317(3): 989-1001, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16525037